Daniel N. Bracey, MD
Wake Forest Graduate School of Arts & Sciences (Molecular Medicine and Translational Science Ph.D. Program)
Wake Forest School of Medicine
University of Virginia
Bryn Mawr, Pennsylvania
Dr. Bracey's primary research focus is in tissue engineering and decellularized xenograft tissues. His PhD work is based on the hypothesis that porcine cancellous bone can be decellularized to successfully produce a biocompatible and osteoconductive bone scaffold. Such a scaffold has the potential to function as an off-the-shelf bone graft substitute to improve the management of large osseous defects, and alleviate the patient morbidity associated with autograft harvest. Dr. Bracey collaborates with former Physician Scientist Residents, Dr. Seyler and Dr. Whitlock, on this project and has been successful in acquiring competitive grants to fund this work.
Additionally, Dr. Bracey is researching the endogenous peptide hormone Angiotensin-(1-7) and its use for the prevention of radiation-induced muscle fibrosis. He is pursuing this interest in a mouse model with collaborators in the Hypertension and Vascular Research Center here at Wake Forest.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.